Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a new version of the study record. This update reflects an administrative revision to the page's documentation rather than changes to the study content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe Sweden location entries were updated to reflect the correct spelling Malmö and two precise site lines: Malmö, Sweden, SE-20502 and Malmö, Skåne County, Sweden, SE-21152. This replaces the previous Malmo entries with standardized naming.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform release rather than a change to the study information.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.5.2 was added and the previous revision v3.5.0 was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedVersion bump from v3.4.2 to v3.4.3; no visible changes to study details or page layout.SummaryDifference0.0%

Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.